These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1199980)

  • 41. [The vaccinal prevention of the HBsAg carrier state among newborn infants].
    Ikoev VN; Gorbunov IA; Anan'ev VA; Noskova AV; Titov IA
    Vopr Virusol; 1991; 36(6):452-4. PubMed ID: 1785176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical hepatitis B in infants born to HBs Ag carrier mothers.
    Phuapradit P; Varavithya W; Theppisai U; Chiewsilp P; Siripunya P; Bunyaratavej S
    J Med Assoc Thai; 1984 Oct; 67 Suppl 2():94-7. PubMed ID: 6512469
    [No Abstract]   [Full Text] [Related]  

  • 43. Persistent HB antigenemia: associated clinical manifestations and hepatic lesions.
    Klatskin G
    Am J Med Sci; 1975; 270(1):33-40. PubMed ID: 171951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Passive immunoprophylaxis of hepatitis B virus infections in newborn infants.
    Farmer K; Gunn T; Woodfield DG
    N Z Med J; 1985 Oct; 98(788):851-3. PubMed ID: 3864038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fatal hepatitis B in infant born to a HBsAg carrier with HBeAb.
    Ewing CI; Davidson DC
    Arch Dis Child; 1985 Mar; 60(3):265-7. PubMed ID: 3985661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA.
    Ip HM; Lelie PN; Wong VC; Kuhns MC; Reesink HW
    Lancet; 1989 Feb; 1(8635):406-10. PubMed ID: 2563788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Combined passive and active immunization for preventing the development of the infantile carrier state in hepatitis B virus vertical transmission].
    Ijichi M; Inaba N; Takamizawa H; Ohkawa R
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Feb; 39(2):263-70. PubMed ID: 3819521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of hepatitis B immune globulin in prevention of perinatal transmission of the hepatitis B virus.
    Nair PV; Weissman JY; Tong MJ; Thursby MW; Paul RH; Henneman CE
    Gastroenterology; 1984 Aug; 87(2):293-8. PubMed ID: 6376265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms of maternal-fetal transmission of hepatitis B virus.
    Lee AK; Ip HM; Wong VC
    J Infect Dis; 1978 Nov; 138(5):668-71. PubMed ID: 712120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fatal hepatitis B in early infancy: the importance of identifying HBsAg-positive pregnant women and providing immunoprophylaxis to their newborns.
    Delaplane D; Yogev R; Crussi F; Shulman ST
    Pediatrics; 1983 Aug; 72(2):176-80. PubMed ID: 6683400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Materno-fetal transmission of hepatitis B virus in Ivory Coast. Plea for mass vaccination].
    Lohouès-Kouacou MJ; Touré M; Hillah J; Camara BM; N'Dri N; Kouamé KJ; Attia Y
    Sante; 1998; 8(6):401-4. PubMed ID: 10064911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Asymptomatic carriers of HB antigen--infectivity of HB antigen and HB core].
    Ichida F
    Nihon Rinsho; 1974 Dec; 32(12):3458-63. PubMed ID: 4617013
    [No Abstract]   [Full Text] [Related]  

  • 54. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
    Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL
    Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Severe neonatal hepatitis B transmitted by asymptomatic carrier mother (author's transl)].
    Ruiz Extremera A; Salmerón Escobar FJ; Loscertales Abril M; López Cueto A; Hernández Gómez MV; Bernal Zamora C; Molina Font JA
    An Esp Pediatr; 1981 Sep; 15(3):284-8. PubMed ID: 7332140
    [No Abstract]   [Full Text] [Related]  

  • 56. Hepatitis associated antigen (HAA) in pregnant women and their newborn infants.
    Skinhoj P; Sardemann H; Cohn J; Mikkelsen M; Olesen H
    Am J Dis Child; 1972 Apr; 123(4):380-1. PubMed ID: 5027549
    [No Abstract]   [Full Text] [Related]  

  • 57. A combination of hepatitis B vaccine and immunoglobulin does not protect all infants born to hepatitis B e antigen positive mothers.
    Farmer K; Gunn T; Woodfield DG
    N Z Med J; 1987 Jul; 100(827):412-4. PubMed ID: 2967932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B miniepidemic in a peritoneal dialysis unit.
    Spector D
    Arch Intern Med; 1977 Aug; 137(8):1030-1. PubMed ID: 879940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The incidence of the HBsAg carrier state among pregnant women and its effect on newborn infants. III. Viral hepatitis morbidity among the infants born to mothers who are HBsAg carriers].
    Iliev B; Stambolov B; Khristov M; Marinova E
    Akush Ginekol (Sofiia); 1988; 27(4):44-9. PubMed ID: 3218680
    [No Abstract]   [Full Text] [Related]  

  • 60. [Antigen e and its antibodies in acute serum hepatitis and in persons with a prolonged HBs-antigenemia].
    Paktoris EA; Trofimova LI; Sergeeva NA; Sinaĭko GA; Shakhgil'dian IV
    Vopr Virusol; 1979; (2):156-61. PubMed ID: 107654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.